DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

June 18, 2021

Primary Completion Date

October 31, 2024

Study Completion Date

April 30, 2025

Conditions
Relapsed Diffuse Large B-cell LymphomaRefractory Diffuse Large B-cell Lymphoma
Interventions
DRUG

DPX-Survivac

SC injection on D7 and D28, then every 8 weeks

DRUG

Pembrolizumab

IV infusion every 3 weeks

DRUG

CPA

50 mg twice daily, week on then week off

Trial Locations (50)

2145

RECRUITING

Westmead Hospital, Westmead

3002

RECRUITING

Epworth Freemasons Hospital, Melbourne

3128

RECRUITING

Box Hill Hospital, Melbourne

4032

RECRUITING

Debreceni Egyetem Klinikai Központ, Debrecen

4400

RECRUITING

SzSzBM Korhazak es Egyetemi Oktatokorhaz, Nyíregyháza

4414

RECRUITING

Palmerston North Hospital, Palmerston North

5000

RECRUITING

Royal Adelaide Hospital, Adelaide

11000

RECRUITING

University Clinical Center of Serbia, Belgrade

11080

RECRUITING

Clinical Hospital Center Zemun, Zemun

15224

RECRUITING

Allegheny Health Network (AHN) West Penn Hospital, Pittsburgh

19611

RECRUITING

Reading Hospital - McGlinn Cancer Institute, West Reading

21204

RECRUITING

Oncology Institute of Vojvodina, Kamenitz

24019

RECRUITING

Centre Hospitalier de Périgueux, Périgueux

27834

RECRUITING

Brody School of Medicine at East Carolina University, Greenville

30342

RECRUITING

Blood and Marrow Transplant Group of Georgia, Atlanta

33021

WITHDRAWN

BRCR Medical Center Inc., Hollywood

33322

WITHDRAWN

BRCR Medical Center Inc., Plantation

33486

WITHDRAWN

Boca Raton Regional Hospital, Boca Raton

33600

RECRUITING

CHU Bordeaux- Hôpital Haut Lévêque, Pessac

33709

WITHDRAWN

Comprehensive Hematology and Oncology, St. Petersburg

34000

RECRUITING

University Clinical Center Kragujevac, Kragujevac

41013

RECRUITING

Hospital Universitario Virgen del Rocío, Seville

43614

WITHDRAWN

University of Toledo Medical Center, Toledo

43623

RECRUITING

Toledo Clinic Cancer Center, Toledo

44277

RECRUITING

Hôpital Privé du Confluent, Nantes

44718

WITHDRAWN

Gabrail Cancer Center Research, Canton

46202

RECRUITING

Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis

54000

RECRUITING

Centre d'Oncologie de Gentilly, Nancy

57201

WITHDRAWN

Prairie Lakes Health Care System, Watertown

68130

RECRUITING

Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha

70112

RECRUITING

Tulane Cancer Center Office of Clinical Research, New Orleans

75012

RECRUITING

Hôpital Saint-Antoine, Paris

75013

RECRUITING

Hôpital de la Pitié-Salpêtrière, Paris

75015

RECRUITING

Hôpital Necker, Paris

87505

RECRUITING

Christus St. Vincent Regional Cancer Center, Santa Fe

92708

RECRUITING

Compassionate Cancer Care Medical Group, Fountain Valley

93000

RECRUITING

Hôpital Avicenne, Bobigny

400015

RECRUITING

"The Oncology Institute Prof. Dr. Ion Chiricuţă I.O.C.H.", Cluj-Napoca

S7H 4H4

RECRUITING

Saskatoon Cancer Center, Saskatoon

06189

RECRUITING

Centre Antoine Lacassagne, Nice

02321

RECRUITING

Centre Hospitalier de Saint-Quentin, Saint-Quentin

0622

RECRUITING

North Shore Hospital, Auckland

85-519

RECRUITING

Szpitale Pomorskie Sp. z o. o., Gdynia

59-220

RECRUITING

Wojewódzki Szpital Specjalistyczny w Legnicy, Legnica

10-228

RECRUITING

SP ZOZ MSWiA z Warmińsko-Mazurskim Centrum Onkologii w Olsztynie, Olsztyn

60-185

RECRUITING

Centrum Medyczne Pratia Poznań, Skórzewo

02-781

RECRUITING

Narodowy Instytut Onkologii im. Marii, Skłodowskiej-Curie, Warsaw

022328

RECRUITING

"Bucharest Oncology Institute Prof.Dr.Al. Trestioreanu", Bucharest

08041

RECRUITING

Hospital Santa Creu i Sant Pau, Barcelona

09006

RECRUITING

Hospital Universitario de Burgos, Burgos

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

ImmunoVaccine Technologies, Inc. (IMV Inc.)

INDUSTRY